High Levels of Platelet-Lymphocyte Complexes in Patients with Psoriasis Are Associated with a Better Response to Anti–TNF-α Therapy
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (6) , 1176-1183
Abstract
No abstract availableKeywords
Funding Information
- AbbVie (IIBSP-ADA-2013-63, ACA-SPAI-13-07)
This publication has 42 references indexed in Scilit:
- Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectinBlood, 2016
- Increased expression of interleukin‐17 pathway genes in nonlesional skin of moderate‐to‐severe psoriasis vulgarisBritish Journal of Dermatology, 2015
- Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis?Clinica Chimica Acta, 2015
- Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic ArthritisArthritis & Rheumatology, 2014
- Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohortJournal of the European Academy of Dermatology and Venereology, 2014
- Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional PathwaysJournal of Investigative Dermatology, 2012
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in PsoriasisJournal of Investigative Dermatology, 2011
- Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humansThrombosis and Haemostasis, 2011
- Platelet P‐selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasisExperimental Dermatology, 2010
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007